Merosin or laminin alpha 2 chain deficiency (Q103659): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| Property / Collection date | |||||||||||||||
16 August 2026
| |||||||||||||||
| Property / Collection date: 16 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 09:25, 17 August 2026
Merosin-deficient congenital muscular dystrophy belongs to a group of neuromuscular disorders with onset at birth or infancy characterised by hypotonia, muscle weakness and muscle wasting. Merosin-deficient congenital muscular dystrophy represents 30-40% of congenital muscular dystrophies.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1693850954 |
||
| English | Merosin or laminin alpha 2 chain deficiency |
Merosin-deficient congenital muscular dystrophy belongs to a group of neuromuscular disorders with onset at birth or infancy characterised by hypotonia, muscle weakness and muscle wasting. Merosin-deficient congenital muscular dystrophy represents 30-40% of congenital muscular dystrophies. |
Statements
CID11:ID_1693850954
0 references
dki-india-ID_1693850954
0 references
Concluído
0 references
16 August 2026
0 references
